Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: Choline levels and MR diffusion constants initial experience

被引:137
作者
Chen, CY
Li, CW
Kuo, YT
Jaw, TS
Wu, DK
Jao, JC
Hsu, JS
Liu, GC
机构
[1] Kaohsiung Med Univ, Dept Med Imaging, Kaohsiung 807, Taiwan
[2] Kaohsiung Med Univ, Sch Med Radiat Technol, Kaohsiung 807, Taiwan
关键词
D O I
10.1148/radiol.2392042202
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To prospectively investigate the apparent diffusion coefficient (ADC) and choline levels measured at hydrogen 1 (H-1) magnetic resonance (MR) spectroscopy, to monitor therapeutic responses of hepatocellular carcinoma (HCC) to transcatheter arterial chemoembolization (TACE). Materials and Methods: Institutional review board approval was obtained, and all patients and control subjects provided informed consent. Histologically proved large HCCs (> 3 cm in diameter) were evaluated in 20 patients (16 men and four women; mean age, 59 years; range, 34-80 years) before TACE and 2-3 days after TACE. A control group of eight adults (five men and three women; mean age, 43 years; range, 24-76 years) with normal livers was examined by using the same protocol. Hepatic choline levels were measured by means of an external phantom replacement method, quantifying the peak at 3.2 ppm at H-1 MR spectroscopy. ADCs were measured for all lesions. A Wilcoxon rank sum test was used to compare absolute choline concentrations and ADCs at baseline between HCCs and normal liver parenchyma. Changes in choline levels and ADCs in the tumors before and after TACE were analyzed by using the Wilcoxon signed rank test. Results: The median preoperative choline level in patients with HCC (measured in 18 of the 20 patients) was 4.0 mmol/L (range, 0.0-17.2 mmol/L), which was significantly higher than that in patients with normal livers (n = 8) (median, 1.6 mmol/L; range, 0.0-2.1 mmol/L; P < .01). Among 18 patients with HCC, choline levels decreased significantly from before TACE to after TACE (P < .01). A significant increase in ADC from before TACE to after TACE in the 20 patients with HCC was also found (P < .01). Conclusion: Hepatic choline levels and ADCs may allow monitoring of therapeutic responses of HCC to TACE although larger, more definitive and quantitative studies with clinical end points are needed.
引用
收藏
页码:448 / 456
页数:9
相关论文
共 48 条
[1]   In vivo proton (H1) magnetic resonance spectroscopy for cervical carcinoma [J].
Allen, JR ;
Prost, RW ;
Griffith, OW ;
Erickson, SJ ;
Erickson, BA .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (05) :522-529
[2]   Diffusion-weighted imaging with navigated interleaved echo-planar imaging and a conventional gradient system [J].
Bammer, P ;
Stollberger, R ;
Augustin, M ;
Simbrunner, J ;
Offenbacher, H ;
Kooijman, H ;
Ropele, S ;
Kapeller, P ;
Wach, P ;
Ebner, F ;
Fazekas, F .
RADIOLOGY, 1999, 211 (03) :799-806
[3]   Improved diffusion-weighted single-shot echo-planar imaging (EPI) in stroke using Sensitivity Encoding (SENSE) [J].
Bammer, R ;
Keeling, SL ;
Augustin, M ;
Pruessmann, KP ;
Wolf, R ;
Stollberger, R ;
Hartung, HP ;
Fazekas, F .
MAGNETIC RESONANCE IN MEDICINE, 2001, 46 (03) :548-554
[4]   RESPONSE OF NON-HODGKIN-LYMPHOMA TO RADIATION-THERAPY - EARLY AND LONG-TERM ASSESSMENT WITH H-1 MR SPECTROSCOPIC IMAGING [J].
BIZZI, A ;
MOVSAS, B ;
TEDESCHI, G ;
PHILLIPS, CL ;
OKUNIEFF, P ;
ALGER, JR ;
DICHIRO, G .
RADIOLOGY, 1995, 194 (01) :271-276
[5]  
Bulakbasi N, 2003, AM J NEURORADIOL, V24, P225
[6]   Proton MR spectroscopy in clinical routine [J].
Burtscher, IM ;
Holtås, S .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2001, 13 (04) :560-567
[7]   Diffusion-weighted MR imaging of the liver: distinguishing hepatic abscess from cystic or necrotic tumor [J].
Chan, JHM ;
Tsui, EYK ;
Luk, SH ;
Fung, ASL ;
Yuen, MK ;
Szeto, ML ;
Cheung, YK ;
Wong, KPC .
ABDOMINAL IMAGING, 2001, 26 (02) :161-165
[8]   Chronic hepatitis: In vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings [J].
Cho, SG ;
Kim, MY ;
Kim, HJ ;
Kim, YS ;
Choi, W ;
Shin, SH ;
Hong, KC ;
Kim, YB ;
Lee, JH ;
Suh, CH .
RADIOLOGY, 2001, 221 (03) :740-746
[9]  
Colombo M, 2001, HEPATO-GASTROENTEROL, V48, P25
[10]  
DeSantis M, 1997, EUR RADIOL, V7, P10